Test Directory

Test Code
PREKA
Test Name
Prekallikrein
CPT Codes
85292
Expected Turnaround Time
4 - 8 days
Clinical Utility

This test is used for the measurement of prekallikrein factor activity.

Specimen and Container Info

Specimen Type: Citrated Platelet-Poor Plasma

  

Collection Container: Light Blue Top (Sodium Citrate)

Desired Specimen Volume: 1 mL

Collection Instructions
  1. Collect a light blue top (sodium citrate) tube via venipuncture
  2. Evacuated collection tubes must be filled to completion to ensure a proper blood-to-anticoagulant ratio.
  3. The sample should be mixed immediately by gentle inversion at least six times to ensure adequate mixing of the anticoagulant with the blood.
  4. A discard tube is not required prior to collection of coagulation samples unless the sample is collected using a winged (butterfly) collection system. With a winged blood collection set a discard tube should be drawn first to account for the dead space of the tubing and prevent under-filling of the evacuated tube.
  5. When noncitrate tubes are collected for other tests, collect sterile and nonadditive (red-top) tubes prior to citrate (blue-top) tubes. Any tube containing an alternative anticoagulant should be collected after the blue-top tube. Gel-barrier tubes and serum tubes with clot initiators should also be collected after the citrate tubes.
Processing and Submission Instructions

 Platelet-Poor Plasma Processing Instructions

  1. Perform platelet-poor plasma procedure.
  2. Transfer 1 mL of platelet poor plasma to a LabCorp pp transpak frozen purple tube.
  3. Freeze immediately.
  4. To avoid delays in turnaround time when requesting multiple tests on frozen samples, please submit separate frozen specimens for each test requested.
Patient Preparation

Do not draw from an arm with a heparin lock or heparinized catheter.

Transport Instructions

Transport to the laboratory frozen. 

Stability Requirements

Room Temperature

4 hours

Frozen

9 months

Methodology
Clot Based Assay
Reference Intervals

 See patient report.

Limitations

Plasmas deficient in FXII may give falsely low results. Lupus anticoagulants and other non-specific factor inhibitors may also interfere with this assay. Heparin, direct Xa or thrombin inhibitor therapy may have an effect on factor assays.

Alternate Names
  •  Fletcher Factor Assay
Reference Lab
Labcorp Of America Holdings
Testing Schedule
Routine, 1 time per week